Sulindac in familial adenomatous polyposis: Evaluation by nuclear morphometry

European Journal of Surgery

Volumn 167, Issue 5, 2001, Pages 375-381

  Fernandez Lopez F ^a   Conde Freire, R ^a   Cadarso Suarez C ^a   Garcia Iglesias J ^a   Puente Dominguez J L ^a   Potel Lesquereux, J ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

FAP; Morphometry; Sulindac

Indexed keywords

SULINDAC;

ADENOMATOUS POLYP; ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CELL PROLIFERATION; CLINICAL ARTICLE; COLON MUCOSA; COLON RESECTION; DRUG EFFECT; EPITHELIUM CELL; FAMILIAL DISEASE; FEMALE; HUMAN; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; RECTUM; SULINDAC;

EID: 0034986269     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241501750215285     Document Type: Article

References (31)

1. Pronostic value of morphometry in papillary thyroid carcinoma
2. Quantitative analysis of borderline and malignant mucinous ovarian tumours
3. The value of morphometry to classic prognosticators in breast cancer
4. Sulindac suppresses tumorigenesis in the Min mouse
5. Comparasion of aspiration, touch and scrape preparations simultaneously obtained from surgically excised specimens
6. Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype
7. Inhibition of lung tomourigenesis by sulindac: Comparison of two experimental protocols
8. Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis
9. A new method to assess metastatic potential of human prostate cancer: Relative nuclear roundess
10. Nonsteroidal anti-infammatory drugs, eicosanoids, and colorectal cancer prevention
11. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: Evaluation of predictive factors
12. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
13. Effect of indomethacine suppositories on rectal polyposis in patients with familial adenomatous polyposis
14. Computerized nuclear morphometry. A new morphologic assessment for advanced gastric adenocarcinoma
15. Rectal cancer after prolonged sulindac chemoprevention. A case report
16. Effects of sulindac on sporadic colorectal adenomatous polyps
17. Nuclear shape as a prognostic discriminant in colorectal carcinoma
18. The value of nuclear morphometry in the management of patients with colorectal polyps that contain invasive adenocarcinoma
19. Mutations of chromosome 5q2 genes in FAP and colorectal cancer patients
20. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
21. Sulindac sulfide inhibits the proliferation of colon cancer cells: Diminished expression of the proliferation markers PCNA and Ki-97
22. Comparison of classic and quantitative prognostic factors in colorectal cancer
23. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methycaffeate, and 6-phenylhexyl isothiocyanate apoptptic index as a biomarker in colon cancer chemoprevention and promotion
24. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: An in vitro study
25. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment
26. Aberrant crypt foci of the colon as precursors of adenoma and cancer
27. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
28. Sulindac therapy of colorectal polyps in familial adenomatous polyposis
29. Genetic alterations during colorectal tumor development
30. Sulindac for polyposis of the colon
31. The NSAID sulindac reverses rectal adenomas in colectomized patiens with familial adenomatous polyposis: Clinical results of a dose-finding study on rectal sulindac administration